WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE)
WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE)
WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE)

WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE)

3000 INR/Piece

Product Details:

  • Drug Type Injection
  • Physical Form Other
  • Dosage 2.4 mg
  • Click to View more
X

WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) Price And Quantity

  • 3000 INR/Piece
  • 100.00 - 1000.00 INR/Piece
  • 10 Piece

WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) Product Specifications

  • 2.4 mg
  • Injection
  • Other

WEGOVY INJECTION 2.4 MG (SEMAGLUTIDE) Trade Information

  • Western Union
  • 100 Piece Per Day
  • 10 Days
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Product Description

Wegovy (semaglutide) 2.4 mg is a once-weekly injectable medication used for chronic weight management in adults with obesity or overweight, along with at least one weight-related condition (such as type 2 diabetes, high blood pressure, or high cholesterol).

This 2.4 mg dose is the full maintenance dose and is prescribed after a gradual titration process that helps patients safely build up to this level. Wegovy works by mimicking the GLP-1 hormone, which regulates appetite and food intake. It helps reduce hunger, increase satiety (the feeling of fullness), and support long-term weight loss when combined with a reduced-calorie diet and increased physical activity.

Wegovy 2.4 mg is not intended for cosmetic weight loss or short-term use. It is part of a long-term medical approach to healthy, sustainable weight reduction.


FAQs about Wegovy 2.4 mg Injection

1. What is Wegovy 2.4 mg used for?

Wegovy 2.4 mg is the maintenance dose used for ongoing weight loss and weight management. After completing the dose escalation schedule (0.25 mg to 1.7 mg), most patients stay on 2.4 mg weekly to achieve and maintain weight loss goals.

2. Who is eligible for Wegovy 2.4 mg?

Wegovy is intended for adults who meet either of the following:

  • BMI ï30 (obese)

  • BMI ï27 (overweight) with at least one weight-related condition (e.g., high blood pressure, type 2 diabetes, or dyslipidemia)

3. How do I take Wegovy 2.4 mg?

  • Inject subcutaneously once weekly, on the same day each week.

  • Can be taken with or without food, at any time of day.

  • Common injection sites: abdomen, upper arm, or thigh

  • Always rotate injection sites to prevent irritation.

4. How long can I stay on the 2.4 mg dose?

The 2.4 mg dose is designed for long-term use, as long as it is well-tolerated and continues to provide benefit. Your healthcare provider will monitor your progress and adjust treatment as needed.

5. What side effects should I watch for at this dose?

Common side effects may include:

  • Nausea

  • Vomiting

  • Diarrhea or constipation

  • Abdominal pain

  • Headache

  • Fatigue

  • Injection site reactions

These often lessen over time. Serious but rare side effects include pancreatitis, gallbladder issues, or thyroid tumors. Contact your healthcare provider if you experience severe or persistent symptoms.

6. What should I do if I miss a dose?

  • If less than 5 days have passed: take the missed dose as soon as possible.

  • If more than 5 days have passed: skip the missed dose and resume with your next scheduled dose.

  • Do not double up doses to make up for a missed one.

7. Can I stop at 2.4 mg or lower the dose if needed?

Yes. Some patients may remain on a lower dose (like 1.7 mg) if they do not tolerate 2.4 mg well. However, 2.4 mg is the FDA-approved maintenance dose for optimal effectiveness. Your provider will help you determine the best dose for your body and goals.

8. How effective is Wegovy at the 2.4 mg dose?

In clinical trials, patients taking Wegovy 2.4 mg lost an average of 15% of their body weight over 68 weeks when combined with a healthy diet and exercise plan. Some patients lost up to 20% of their starting weight.

9. Is Wegovy 2.4 mg safe for everyone?

Wegovy is not recommended for:

  • People with a personal/family history of medullary thyroid carcinoma (MTC) or MEN2

  • Those with a history of severe allergic reactions to semaglutide

  • Pregnant or breastfeeding women

Always consult a healthcare professional before starting or continuing treatment.


Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Semaglutide' category



Back to top